Showing results (361-370 of 617) with videos related to
Sort By:
Pageof 62
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 13, 2005
Retrospective review: re-treatment of patients with ovarian cancer with carboplatin after platinum resistanceH T See, R S Freedman, A P Kudelka, et al.American Journal of Obstetrics and Gynecology|April 4, 2006
Usefulness of preoperative lymphoscintigraphy in patients who undergo radical hysterectomy and pelvic lymphadenectomy for cervical cancerMichael Frumovitz, Robert L Coleman, Isis W Gayed, et al.Gynecologic Oncology|March 1, 1991
Prospective treatment of advanced or recurrent endometrial carcinoma with cisplatin, doxorubicin, and cyclophosphamideT W Burke, C A Stringer, M Morris, et al.Gynecologic Oncology|November 7, 2000
Survey of female gynecologic oncologists and fellows: balancing professional and personal lifeM E Gordinier, L M Ramondetta, L P Parker, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 6, 2020
Phase 2 study of cetuximab (Erbitux) in patients with progressive or recurrent endometrial cancerBrian M Slomovitz, Anca Chelariu-Raicu, Kathleen M Schmeler, et al.Plos One|May 15, 2025
Correction: Sustainable visions: Unsupervised machine learning insights on global development goalsAlberto García-Rodríguez, Matias Núñez, Miguel Robles Pérez, et al.Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|May 11, 2000
Secretion of CXC chemokine IP-10 by peripheral blood mononuclear cells from healthy donors and breast cancer patients stimulated with HER-2 peptidesT V Lee, D K Kim, G E Peoples, et al.Gynecologic Oncology|March 31, 2000
Paget's disease of the vulva: pathology, pattern of involvement, and prognosisL P Parker, J R Parker, D Bodurka-Bevers, et al.Elife|February 6, 2019
Delayed inhibition mechanism for secondary channel factor regulation of ribosomal RNA transcriptionSarah K Stumper, Harini Ravi, Larry J Friedman, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 15, 2005
Multi-institutional phase 2 study of TLK286 (TELCYTA, a glutathione S-transferase P1-1 activated glutathione analog prodrug) in patients with platinum and paclitaxel refractory or resistant ovarian cancerJ J Kavanagh, D M Gershenson, H Choi, et al.Pageof 62